Seminars in Radiation Oncology
Volume 16, Issue 1 , Pages 38-44 , January 2006

Radiation Combined With EGFR Signal Inhibitors: Head and Neck Cancer Focus

  • Paul M. Harari, MD

      Affiliations

    • Corresponding Author InformationAddress reprint requests to Paul M. Harari, MD, Department of Human Oncology, University of Wisconsin Comprehensive Cancer Center, 600 Highland Avenue, Madison, WI 53792
    • ,
  • Shyhmin Huang, PhD

References 

  1. Balaban N , Moni J , Shannon M , et al.   The effect of ionizing radiation on signal transduction (Antibodies to EGF receptor sensitize A431 cells to radiation) . Biochim Biophys Acta . 1996;1314:147–156
  2. Sheridan MT , O’Dwyer T , Seymour CB , et al.   Potential indicators of radiosensitivity in squamous cell carcinoma of the head and neck . Radiat Oncol Invest . 1997;5:180–186
  3. Akimoto T , Hunter NR , Buchmiller L , et al.   Inverse relationship between epidermal growth factor receptor expression and radiocurability of murine carcinomas . Clin Cancer Res . 1999;5:2884–2890
  4. Huang S , Bock JM , Harari PM . Epidermal growth factor receptor blockade with C225 modulates proliferation, apoptosis, and radiosensitivity in squamous cell carcinomas of the head and neck . Cancer Res . 1999;59:1935–1940
  5. Saleh MN , Raisch KP , Stackhouse MA , et al.   Combined modality therapy of A431 human epidermoid cancer using anti-EGFr antibody C225 and radiation . Cancer Biother Radiopharm . 1999;14:451–463
  6. Bonner JA , Harari PM , Giralt J , et al.   Cetuximab prolongs survival in patients with locoregionally advanced squamous cell carcinoma of head and neck (A phase III study of high dose radiation therapy with or without cetuximab) . J Clin Oncol . 2004;22:489s; (abstr 5507)
  7. Harari PM . Epidermal growth factor receptor inhibition strategies in oncology . Endocr Relat Cancer . 2004;11:689–708
  8. Song J , Chen C , Raben D . Emerging role of EGFR-targeted therapies and radiation in head and neck cancer . Oncology . 2004;18:1757–1767
  9. Cohen S . The stimulation of epidermal proliferation by a specific protein (EGF) . Dev Biol . 1965;12:394–407
  10. Cohen S , Carpenter G , King L . Epidermal growth factor-receptor-protein kinase interactions. Co-purification of receptor and epidermal growth factor-enhanced phosphorylation activity . J Biol Chem . 1980;255:4834–4842
  11. Masui H , Kawamoto T , Sato JD , et al.   Growth inhibition of human tumor cells in athymic mice by anti-epidermal growth factor receptor monoclonal antibodies . Cancer Res . 1984;44:1002–1007
  12. Mendelsohn J . Growth factor receptors as targets for antitumor therapy with monoclonal antibodies . Prog Allergy . 1988;45:147–160
  13. Fan Z , Baselga J , Masui H , et al.   Antitumor effect of anti-epidermal growth factor receptor monoclonal antibodies plus cis-diamminedichloroplatinum on well established A431 cell xenografts . Cancer Res . 1993;53:4637–4642
  14. Baselga J , Norton L , Masui H , et al.   Antitumor effects of doxorubicin in combination with anti-epidermal growth factor receptor monoclonal antibodies . J Natl Cancer Inst . 1993;85:1327–1333
  15. Schmidt-Ullrich RK , Mikkelsen RB , Dent P , et al.   Radiation-induced proliferation of the human A431 squamous carcinoma cells is dependent on EGFR tyrosine phosphorylation . Oncogene . 1997;15:1191–1197
  16. Huang S , Harari PM . Epidermal growth factor receptor inhibition in cancer therapy (Biology, rationale and premininary clinical results) . Invest New Drugs . 1999;17:259–269
  17. Bianco C , Bianco R , Tortora G , et al.   Antitumor activity of combined treatment of human cancer cells with ionizing radiation and anti-epidermal growth factor receptor monoclonal antibody C225 plus type I protein kinase A antisense oligonucleotide . Clin Cancer Res . 2000;6:4343–4350
  18. Huang S-M , Harari PM . Modulation of radiation response after epidermal growth factor receptor blockade in squamous cell carcinomas (Inhibition of damage repair, cell cycle kinetics, and tumor angiogenesis) . Clin Cancer Res . 2000;6:2166–2174
  19. Milas L , Mason K , Hunter N , et al.   In vivo enhancement of tumor radioresponse by C225 antiepidermal growth factor receptor antibody . Clin Cancer Res . 2000;6:701–708
  20. Rao GS , Murray S , Ethier SP . Radiosensitization of human breast cancer cells by a novel ErbB family receptor tyrosine kinase inhibitor . Int J Radiat Oncol Biol Phys . 2000;48:1519–1528
  21. Harari PM , Huang S . Modulation of molecular targets to enhance radiation . Clin Cancer Res . 2000;6:323–325
  22. Harari PM , Huang S . Head and neck cancer as a clinical model for molecular targeting of therapy (Combining EGFR blockade with radiation) . Int J Radiat Oncol Biol Phys . 2001;49:427–433
  23. Bianco C , Tortora G , Bianco R , et al.   Enhancement of antitumor activity of ionizing radiation by combined treatment with the selective epidermal growth factor receptor-tyrosine kinase inhibitor ZD1839 (Iressa) . Clin Cancer Res . 2002;8:3250–3258
  24. Huang S , Li J , Armstrong EA , et al.   Modulation of radiation response and tumor-induced angiogenesis after epidermal growth factor receptor inhibition by ZD1839 (Iressa) . Cancer Res . 2002;62:4300–4306
  25. Williams KJ , Telfer BA , Stratford IJ , et al.   ZD1839 (‘Iressa’), a specific oral epidermal growth factor receptor-tyrosine kinase inhibitor, potentiates radiotherapy in a human colorectal cancer xenograft model . Br J Cancer . 2002;86:1157–1161
  26. She YH , Lee F , Chen J , et al.   The epidermal growth factor receptor tyrosine kinase inhibitor ZD1839 selectively potentiates, radiation response of human tumors in nude mice, with a marked improvement in therapeutic index . Clin Cancer Res . 2003;9:3773–3778
  27. Shintani S , Li C , Mihara M , et al.   Enhancement of tumor radioresponse by combined treatment with gefitinib (Iressa, ZD1839), an epidermal growth factor receptor tyrosine kinase inhibitor, is accompanied by inhibition of DNA damage repair and cell growth in oral cancer . Int J Cancer . 2003;107:1030–1037
  28. Solomon B , Hagekyriakou J , Trivett MK , et al.   EGFR blockade with ZD1839 (“Iressa”) potentiates the antitumor effects of single and multiple fractions of ionizing radiation in human A431 squamous cell carcinoma. Epidermal growth factor receptor . Int J Radiat Oncol Biol Phys . 2003;55:713–723
  29. Nyati MK , Maheshwari D , Hanasoge S , et al.   Radiosensitization by Pan ErbB inhibitor CI-1033 in vitro and in vivo . Clin Cancer Res . 2004;10:691–700
  30. Zhou H , Kim Y-S , Peletier A , et al.   Effects of the EGFR/HER2 kinase inhibitor GW572016 on EGFR- and HER2-overexpressing breast cancer cell line proliferation, radiosensitization, and resistance . Int J Radiat Oncol Biol Phys . 2004;58:344–352
  31. Chinnaiyan P , Huang S , Vallabhaneni G , et al.   Mechanisms of enhanced radiation response following epidermal growth factor receptor signaling inhibition by erlotinib (Tarceva) . Cancer Res . 2005;65:3328–3335
  32. Nasu S , Ang KK , Fan Z , et al.   C225 antiepidermal growth factor receptor antibody enhances tumor radiocurability . Int J Radiat Oncol Biol Phys . 2001;51:474–477
  33. Krause M , Schutze C , Petersen C , et al.   Different classes of EGFR inhibitors may have different potential to improve local tumour control after fractionated irradiation (A study on C225 in FaDu hSCC) . Radiother Oncol . 2005;74:109–115
  34. Huang S , Li J , Harari PM . Molecular inhibition of angiogenesis and metastatic potential in human squamous cell carcinomas after epidermal growth factor receptor blockade . Mol Cancer Ther . 2002;1:507–514
  35. Baumann M , Krause M . Targeting the epidermal growth factor receptor in radiotherapy (Radiobiological mechanisms, preclinical and clinical results) . Radiother Oncol . 2004;72:257–266
  36. Robert F , Ezekiel MP , Spencer SA , et al.   Phase I study of anti-epidermal growth factor receptor antibody cetuximab in combination with radiation therapy in patients with advanced head and neck cancer . J Clin Oncol . 2001;19:3234–3243
  37. Bonner JA , Harari PM , Giralt J , et al.   Improved preservation of larynx with the addition of cetuximab to radiation for cancers of the larynx and hypopharynx . J Clin Oncol . 2005;23:508s; (abstr 5533)
  38. Pfister DG , Aliff TB , Kraus DH , et al.   Concurrent cetuximab, cisplatin, and concomitant boost radiation therapy (RT) for locoregionally advanced, squamous cell head and neck cancer (SCCHN) (Preliminary evaluation of a new combined-modality paradigm) . Proc Am Soc Clin Oncol . 2003;22:495; (abstr 1993)
  39. Chakravarti A , Seiferheld W , Robins HI , et al.   An update of phase I data from RTOG 0211 (A phase I/II clinical study of gefitinib+ radiation for newly-diagnosed glioblastoma (GBM) patients) . J Clin Oncol . 2004;22:1571; (abstract)
  40. Ang KK , Berkey BA , Tu X , et al.   Impact of epidermal growth factor receptor expression on survival and pattern of relapse in patients with advanced head and neck carcinoma . Cancer Res . 2002;62:7350–7356
  41. Chua DT , Nicholls JM , Sham JS , et al.   Prognostic value of epidermal growth factor receptor expression in patients with advanced stage nasopharyngeal carcinoma treated with induction chemotherapy and radiotherapy . Int J Radiat Oncol Biol Phys . 2004;59:11–20
  42. Bentzen SM , Atasoy BM , Daley FM , et al.   Epidermal growth factor receptor expression in pre-treatment biopsies from head and neck squamous cell carcinoma as a predictive factor for a benefit from accelerated radiation therapy in a radandomized controlled trial . J Clin Oncol . 2005;23:5560–5567
  43. Chung KY , Shia J , Kemeny NE , et al.   Cetuximab shows activity in colorectal cancer patients with tumors that do not express the epidermal growth factor receptor by immunohistochemistry . J Clin Oncol . 2005;23:1803–1810
  44. Meropol NJ . Epidermal growth factor receptor inhibitors in colorectal cancer (It’s time to get back on target) . J Clin Oncol . 2005;23:1791–1793
  45. Harari PM , Contreras L , Pickart MA , et al.   Modulation of proliferation kinetics in human squamous cell carcinomas of the head and neck . Arch Otolaryngol Head Neck Surg . 1993;119:738–742
  46. Petereit DG , Harari PM , Contreras L , et al.   Combining polyamine depletion with radiation therapy for rapidly dividing head and neck tumors (Strategies for improved locoregional control) . Int J Radiat Oncol Biol Phys . 1994;28:891–898
  47. Lynch TJ , Bell DW , Sordella R , et al.   Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib . N Engl J Med . 2004;350:2129–2139
  48. Paez JG , Janne PA , Lee JC , et al.   EGFR mutations in lung Cancer (Correlation with clinical response to gefitinib therapy) . Science . 2004;304:1497–1500
  49. Giaccone G , Herbst RS , Manegold C , et al.   Gefitinib in combination with gemcitabine and cisplatin in advanced non-small-cell lung cancer (A phase III trial–INTACT 1) . J Clin Oncol . 2004;22:777–784
  50. Herbst RS , Giaccone G , Schiller JH , et al.   Gefitinib in combination with paclitaxel and carboplatin in advanced non-small-cell lung cancer (A phase III trial––INTACT 2) . J Clin Oncol . 2004;22:785–794
  51. Herbst RS , Prager D , Hermann R , et al.   TRIBUTE—A phase III trial of erlotinib HCl (OSI-774) combined with carboplatin and paclitaxel (CP) chemotherapy in advanced non-small cell lung cancer (NSCLC) . J Clin Oncol . 2004;22:619s; (abstr 7011)
  52. Miller VA , Herbst R , Prager D , et al.   Long survival of never smoking non-small cell lung cancer (NSCLC) patients (pts) treated with erlotinib HCl (OSI-774) and chemotherapy (Sub-group analysis of TRIBUTE) . J Clin Oncol . 2004;22:631s; (abstr 7061)
  53. Harari PM , Huang S-M . Searching for reliable epidermal growth factor receptor response predictors (Commentary re M. K. Nyati et al., radiosensitization by Pan-ErbB inhibitor CI-1033 in vitro and in vivo) . Clin Cancer Res . 2004;10:428–432 Clin Cancer Res., 10:691-700, 2004

 Dr. Harari holds research and consulting agreements with AstraZeneca, Genentech, ImClone, Bristol-Myers and Amgen.

PII: S1053-4296(05)00049-4

doi: 10.1016/j.semradonc.2005.08.005

Seminars in Radiation Oncology
Volume 16, Issue 1 , Pages 38-44 , January 2006

Article Tools

* Image Usage & Resolution